Publications by authors named "K C Kato"

Introduction And Importance: Fallopian tube cancer, particularly the carcinosarcoma subtype, is a rare malignancy posing diagnostic challenges.

Case Presentation: Our patient was an 83-year-old, nulligravida woman, presented to our outpatient clinic with one month of pelvic pain. On examination, a pelvic mass was detected.

View Article and Find Full Text PDF

Background: High-intensity exercise is recommended for the pulmonary rehabilitation of patients with chronic obstructive pulmonary disease (COPD); however, it can cause an energy imbalance due to increased energy expenditure. Here, we aimed to explore the effect of reducing exercise intensity on energy balance in patients with COPD experiencing high-intensity training-induced weight loss.

Methods: All participants underwent high-intensity endurance and resistance training for a 2-week preliminary period.

View Article and Find Full Text PDF

The limitations of cloning and discriminating quantum states are related to the non-orthogonality of the states. Hence, understanding the collective features of quantum states is essential for the future development of quantum communications technology. This paper investigates the non-orthogonality of different coherent-state signal constellations used in quantum communications, namely phase-shift keying (PSK), quadrature-amplitude modulation (QAM), and a newly defined signal named the sunflower-like (SUN) coherent-state signal.

View Article and Find Full Text PDF

Per- and polyfluoroalkyl substances (PFAS), also known as "forever chemicals" because of their persistence in the environment, have been used in many commercial applications since the 1940s. Of late, the detection of PFAS in drinking water throughout the United States has raised public and scientific concerns. To understand PFAS exposure trends in the general U.

View Article and Find Full Text PDF

Esophageal squamous cell carcinoma (ESCC) is a prevalent and highly lethal malignancy in Asia. Recent advancements in immune checkpoint inhibitors (ICIs) have markedly transformed the systemic therapy landscape for ESCC. Anti-PD-1-based combination with chemotherapy or with ipilimumab, an anti-CTLA-4 antibody, have been established as the new standard first-line treatments for patients with advanced ESCC.

View Article and Find Full Text PDF